Anatara Lifesciences (ASX:ANR) is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO & Chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.
The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to announce that further to the significant progress that its subsidiary Medical Cannabis Limited has been making in its business and product development, EndoCRO Ltd an iCAN:Israel-Cannabis company, has been selected as a research and product development arm on a contract basis.
The Board of Queensland Bauxite (ASX:QBL) is pleased to announce that the Department of Natural Resources and Mines has now formally approved the Mineral Development License for the South Johnstone Bauxite Project.
As soon as hemp seed food products become legal from November 12, Nimbin-based producer Vitahemp will be ready to start selling.
Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) provides the Company's latest Investor Presentation.
Anatara Lifesciences Ltd (ASX:ANR) provides the Company's Annual Report 2017 Update.
The Directors of Queensland Bauxite Ltd (ASX:QBL) present their report together with the consolidated financial statements of the Group comprising Queensland Bauxite Limited ("the Company" or "QBL") and its subsidiaries, for the financial year ended 30 June 2017 and the independent auditors report thereon.
